Assessment of the Use of a Metabolically-friendly Antiretroviral Regimen to Slow Down the Rate of Progression in Carotid Artery Intima-medial Thickness in Adults With HIV.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Antiretrovirals
- Indications HIV infections
- Focus Pharmacodynamics
- 19 Dec 2014 Biomarkers information updated
- 17 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 Aug 2011 Planned end date changed from 1 Nov 2012 to 1 Nov 2014 as reported by ClinicalTrials.gov.